July 13, 2022 — Black children who underwent heart transplant surgery for the first time were more than three times as likely to die after six months than white children, according to new research published in the 

July 13, 2022 — Adults with abnormal heart metabolism are up to three times more likely to experience life-threatening arrhythmias (an irregular heart rhythm), and MRI techniques could be used to detect the condition and predict future 

July 13, 2022 — Ancora Heart, Inc., a company developing a novel device-based therapy to address heart failure, today announced that the U.S.

July/August 2022 issue of Diagnostic and Interventional Cardiology

View the July/August digital edition of Diagnostic and Interventional Cardiology (DAIC), including links to videos, comparison charts and related content.

Free access to the digital issue

Sign up for a free subscription
 

This issue includes links to the following online content:

July 13, 2022 — Ahead of its 2022 Annual Scientific Meeting, July 15 – 17 in Las Vegas, the Society of Cardiovascular Computed Tomography (SCCT) has announced that seven finalists have been selected for the Best Abstract Award in cardiovascular computed tomography.

July 13, 2022 — The Society of Cardiovascular Computed Tomography (SCCT) has released an update on the device manufacturers set to display their latest technologies at the 2022 Annual Scientific Meeting (SCCT2022) being held in Las Vegas July 15 – 17.

July 12, 2022 — Biotronik announced the presentation of two studies on the performance of its drug-coated balloon catheter 

July 12, 2022 — The Cardiovascular Research Foundation (CRF) and Fogarty Innovation announced today that they are joining forces to launch the "TCT MedTech Innovation Forum” just before the main sessions of TCT (Transcatheter Cardiovascular Therapeutics) 2022, the annual scientific symposium of CRF.

July 12, 2022 — Pesticides and heavy metals in soil may have detrimental effects on the cardiovascular system, according to a review paper published today in Cardiovascular Research, a journal of the European Society of Cardiology (ESC).1  

July 11, 2022 — BioSig Technologies, Inc., a medical technology company advancing electrophysiology workflow by delivering greater intracardiac signal fidelity through its proprietary signal processing platform, today announced that Kansas City Heart Institute at Overland Park Regional Medical Center in Kansas City, U.S. has signed a purchase agreement to acquire its PURE EP(T.M.) System.  

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now